BRIEF-Aeglea Biotherapeutics Presents Trial Data Showing Treatment Effects In Arginase 1 Deficiency Patients
April 12, 2018 at 07:55 AM EDT
* AEGLEA BIOTHERAPEUTICS PRESENTS NEW PHASE 1/2 TRIAL DATA DEMONSTRATING CLINICALLY RELEVANT TREATMENT EFFECTS IN ARGINASE 1 DEFICIENCY PATIENTS AT THE 2018 ACMG ANNUAL CLINICAL GENETICS MEETING
